About Arkray
ARKRAY USA, Inc. is the American subsidiary of ARKRAY, Inc., a global medical device and diagnostics company. The company specializes in diabetes management solutions, clinical diagnostics, and oral wellness products. ARKRAY's diabetes management portfolio includes the GLUCOCARD line of blood glucose meters and test strips (Shine, Expression, and Vital models), along with TechLITE lancets, pen needles, and syringes for consumer healthcare. For professional healthcare settings, ARKRAY offers the Assure product line including blood glucose meters and safety devices. In clinical diagnostics, the company provides HbA1c analyzers (ADAMS A1c HA-8180V), urinalysis systems (AUTION series including ELEVEN, EYE, and MAX models), and dry chemistry analyzers (Abacus 5 and 3CP). ARKRAY emphasizes accuracy that meets FDA requirements while maintaining affordability, particularly in its consumer blood glucose monitoring systems. The company supports healthcare providers with product training, wellness programs, and data management solutions. ARKRAY operates globally with presence across Asia Pacific, Europe, North America, Latin America, Middle East, and Africa, serving consumers with diabetes, healthcare professionals, pharmacies, clinical laboratories, and health systems.
Clinical Focus
Medical conditions and clinical areas addressed by Arkray.
Who It Serves
Milestones & Awards
Recent Milestones
Address change notification on product labeling (February 2025); EFLM European Urinalysis Guideline webinar (October 2024)
Social & Media
Latest Updates
Company Details
- Headquarters
- United States of America
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Cecelia Health
Cecelia Health is a national virtual specialty medical practice providing clinician-led integrated cardiometabolic care. The company delivers coordinated treatment for obesity, diabetes, hypertension, chronic kidney disease, and other connected conditions through licensed clinicians including registered dietitians, nurses, and diabetes care specialists.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.